Macrae Sandy

CIK 00016756871 companyRICHMOND, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001675687

Recent Transactions

49 trades

Tax Payment
SANGAMO THERAPEUTICS, INC$SGMOQ
Common Stock
2026-05-25$0.17/sh−12,613→ 1,895,043 total
Award
SANGAMO THERAPEUTICS, INC$SGMOQ
Stock Option (Right to Buy)
2026-04-01+2,500,000→ 2,500,000 total
Tax Payment
SANGAMO THERAPEUTICS, INC$SGMOQ
Common Stock
2026-02-25$0.47/sh−33,637→ 1,907,656 total
Tax Payment
SANGAMO THERAPEUTICS, INC$SGMOQ
Common Stock
2026-02-24$0.47/sh−5,291→ 1,941,293 total
Tax Payment
SANGAMO THERAPEUTICS, INC$SGMOQ
Common Stock
2026-01-22$0.40/sh−102,950→ 1,946,584 total
Tax Payment
SANGAMO THERAPEUTICS, INC$SGMOQ
Common Stock
2025-11-24$0.42/sh−7,488→ 2,049,534 total
Tax Payment
SANGAMO THERAPEUTICS, INC$SGMOQ
Common Stock
2025-10-22$0.66/sh−126,950→ 2,057,022 total
Tax Payment
SANGAMO THERAPEUTICS, INC$SGMOQ
Common Stock
2025-08-24$0.59/sh−7,488→ 2,183,972 total
Tax Payment
SANGAMO THERAPEUTICS, INC$SGMOQ
Common Stock
2025-07-22$0.48/sh−126,950→ 2,191,460 total
Tax Payment
SANGAMO THERAPEUTICS, INC$SGMOQ
Common Stock
2025-05-24$0.47/sh−7,488→ 2,318,410 total
Tax Payment
SANGAMO THERAPEUTICS, INC$SGMOQ
Common Stock
2025-04-22$0.78/sh−126,950→ 2,325,898 total
Tax Payment
SANGAMO THERAPEUTICS, INC$SGMOQ
Common Stock
2025-02-25$0.96/sh−10,663→ 2,077,848 total
Award
SANGAMO THERAPEUTICS, INC$SGMOQ
Common Stock
2025-02-25+375,000→ 2,452,848 total
Award
SANGAMO THERAPEUTICS, INC$SGMOQ
Stock Option (Right to Buy)
2025-02-25+1,750,000→ 1,750,000 total
Tax Payment
SANGAMO THERAPEUTICS, INC$SGMOQ
Common Stock
2025-02-24$1.00/sh−7,488→ 2,088,511 total
Tax Payment
SANGAMO THERAPEUTICS, INC$SGMOQ
Common Stock
2025-01-22$1.15/sh−412,584→ 2,095,999 total
Tax Payment
SANGAMO THERAPEUTICS, INC$SGMOQ
Common Stock
2024-11-25$1.94/sh−10,642→ 2,508,583 total
Tax Payment
SANGAMO THERAPEUTICS, INC$SGMOQ
Common Stock
2024-11-24$1.88/sh−7,473→ 2,519,225 total
Tax Payment
SANGAMO THERAPEUTICS, INC$SGMOQ
Common Stock
2024-08-25$0.86/sh−7,492→ 2,526,698 total
Tax Payment
SANGAMO THERAPEUTICS, INC$SGMOQ
Common Stock
2024-08-24$0.86/sh−5,261→ 2,534,190 total
Tax Payment
SANGAMO THERAPEUTICS, INC$SGMOQ
Common Stock
2024-05-25$0.60/sh−7,492→ 2,539,451 total
Tax Payment
SANGAMO THERAPEUTICS, INC$SGMOQ
Common Stock
2024-05-24$0.60/sh−5,261→ 2,546,943 total
Tax Payment
SANGAMO THERAPEUTICS, INC$SGMOQ
Common Stock
2024-02-25$1.13/sh−24,157→ 2,552,204 total
Tax Payment
SANGAMO THERAPEUTICS, INC$SGMOQ
Common Stock
2024-02-24$1.13/sh−16,115→ 2,576,361 total
Award
SANGAMO THERAPEUTICS, INC$SGMOQ
Common Stock
2024-01-22+2,000,000→ 2,592,476 total
Tax Payment
SANGAMO THERAPEUTICS, INC$SGMOQ
Common Stock
2023-11-25$0.38/sh−10,411→ 592,476 total
Tax Payment
SANGAMO THERAPEUTICS, INC$SGMOQ
Common Stock
2023-08-25$0.77/sh−10,411→ 602,887 total
Tax Payment
SANGAMO THERAPEUTICS, INC$SGMOQ
Common Stock
2023-05-25$1.33/sh−10,411→ 613,298 total
Tax Payment
SANGAMO THERAPEUTICS, INC$SGMOQ
Common Stock
2023-02-25$2.66/sh−54,767→ 623,709 total
Award
SANGAMO THERAPEUTICS, INC$SGMOQ
Common Stock
2023-02-24+157,300→ 678,476 total
Award
SANGAMO THERAPEUTICS, INC$SGMOQ
Stock Option (Right to Buy)
2023-02-24+734,050→ 734,050 total
Award
SANGAMO THERAPEUTICS, INC$SGMOQ
Common Stock
2022-02-25+224,000→ 521,176 total
Award
SANGAMO THERAPEUTICS, INC$SGMOQ
Stock Option (Right to Buy)
2022-02-25+604,800→ 604,800 total
Tax Payment
SANGAMO THERAPEUTICS, INC$SGMOQ
Common Stock
2022-02-25$5.90/sh−49,890→ 297,176 total
Tax Payment
SANGAMO THERAPEUTICS, INC$SGMOQ
Common Stock
2021-02-25$11.19/sh−35,311→ 208,691 total
Award
SANGAMO THERAPEUTICS, INC$SGMOQ
Stock Option (Right to Buy)
2021-02-25+276,750→ 276,750 total
Award
SANGAMO THERAPEUTICS, INC$SGMOQ
Common Stock
2021-02-25+138,375→ 347,066 total
Tax Payment
SANGAMO THERAPEUTICS, INC$SGMOQ
Common Stock
2021-01-24$14.95/sh−3,977→ 244,002 total
Award
SANGAMO THERAPEUTICS, INC$SGMOQ
Common Stock
2020-02-25+168,750→ 247,979 total
Tax Payment
SANGAMO THERAPEUTICS, INC$SGMOQ
Common Stock
2020-02-25$6.80/sh−7,264→ 79,229 total
Award
SANGAMO THERAPEUTICS, INC$SGMOQ
Stock Option (Right-to-Buy)
2020-02-25+337,500→ 337,500 total
Tax Payment
SANGAMO THERAPEUTICS, INC$SGMOQ
Common Stock
2020-01-24$7.50/sh−4,283→ 86,493 total
Award
SANGAMO THERAPEUTICS, INC$SGMOQ
Stock Option (Right-to-Buy)
2019-02-25+379,500→ 379,500 total
Award
SANGAMO THERAPEUTICS, INC$SGMOQ
Common Stock
2019-02-25+63,250→ 90,776 total
Tax Payment
SANGAMO THERAPEUTICS, INC$SGMOQ
Common Stock
2018-01-24$11.10/sh−3,974→ 27,526 total
Award
SANGAMO THERAPEUTICS, INC$SGMOQ
Stock Option (Right to Buy)
2018-01-24+189,000→ 189,000 total
Award
SANGAMO THERAPEUTICS, INC$SGMOQ
Common Stock
2018-01-24+31,500→ 31,500 total
Award
SANGAMO THERAPEUTICS, INC$SGMOQ
Employee Stock Option (Right to Buy)
2017-01-26+360,000→ 360,000 total
Award
SANGAMO THERAPEUTICS, INC$SGMOQ
Employee Stock Option (Right to Buy)
2016-06-03+700,000→ 700,000 total

Companies

SANGAMO THERAPEUTICS, INC
Director, PRESIDENT, CEO AND DIRECTOR
$SGMOQ

Recent Filings

Address

C/O SANGAMO THERAPEUTICS, INC. 501 CANAL BLVD.

RICHMOND, CA, 94804

View on SEC.gov